The following temporary anatomical therapeutic chemical (ATC) classifications and defined daily doses (DDDs) were agreed at a meeting of the WHO International Working Group for Drug Statistics Methodology which took place on 21 October 2001. Comments or objections to the decisions from the meeting should be forwarded to the WHO Collaborating Centre for Drug Statistics Methodology, e-mail: whocc@nmd.no. If no objections are received, the new ATC codes and DDDs will be considered final and will be included in the January 2003 issue of the ATC index. The inclusion of a substance in the lists does not imply any recommendation of use in medicine or pharmacy.

ATC level

INN/common name

ATC code

New ATC level codes (other than 5^th levels):

Other antihypertensives

C02KX

New ATC 5th level codes:

aminolevulinic acid

L01XD04

apomorphine

G04BE07

bosentan

C02KX01

butenafine

D01AE23

calcipotriol, combinations

D05AX52

choriogonadotropin alfa

G03GA08

delapril and calcium channel blockers

C09BB12

dutasteride

G04CB02

eletriptan

N02CC06

famotidine, combinations

A02BA53

ferric sodium gluconate complex

B03AC07

fondaparinux sodium

B01AX05

gepirone

N06AX19

lafutidine

A02BA08

meningococcus C, purified
polysaccharides antigen conjugated

J07AH07

miglustat

A16AX06

pegfilgrastim

L03AA13

seratrodast

R03DX06

simvastatin, combination packages

C10AA51

sulphur hexafluoride

V08DA05

tadalafil

G04BE08

tenecteplase

B01AD11

teriparatide

H05AA02

voriconazole

J02AC03

xaliproden

N07XX03

ATC name changes:

Previous:

parathyroid hormones

HO5A

New:

parathyroid hormones and analogues

H05AA

INN/common name

DDD

Unit

Route of
Administration

ATC code

agalsidase alfa

1

mg

P

A16AB03

agalsidase beta

5

mg

P

A16AB04

amisulpride

0.1

g

O

N05AL05

amprenavir

2.4

g

O

J05AE05

apomorphine*

2

mg

SL

G04BE07

ascorbic acid

0.25

g

V

G01AD03

baclofen

0.55

mg

P

M03BX01

bisoxatin

0.12

g

O

A06AB09

diosmectite

9

g

O

A07BC05

eletriptan*

40

mg

O

N02CC06

estradiol

0.3

mg

N

G03CA03

lafutidine*

20

mg

O

A02BA08

levosimendan

11

mg

P

C01CX08

linezolid

1.2

g

O, P

J01XX08

lopinavir

8

g

O

J05AE06

lornoxicam

12

mg

P, R

M01AC05

lutropin alfa

75

U

P

G03GA07

naltrexone

50

mg

O

N07BB04

nateglinide

0.36

g

O

A10BX03

rasburicase

14

mg

P

V03AF07

rupatadine

10

mg

O

R06AX28

sibutramine

10

mg

O

A08AA10

sirolimus

6

mg

O

L04AA10

sodium selenite*

0.2

mg

O, P

A12CE02

terlipressin

12

mg

P

H01BA04

unoprostone

0.2

ml

S01EX04

DDD changes:

Previous: budesonide

0.3

mg

N

New. budesonide

0.2

mg

N

R01AD05